These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6682146)

  • 1. The antihypertensive and positive inotropic diterpene forskolin: effects of structural modifications on its activity.
    Bhat SV; Dohadwalla AN; Bajwa BS; Dadkar NK; Dornauer H; de Souza NJ
    J Med Chem; 1983 Apr; 26(4):486-92. PubMed ID: 6682146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohli: Forskolin.
    Lindner E; Dohadwalla AN; Bhattacharya BK
    Arzneimittelforschung; 1978; 28(2):284-9. PubMed ID: 580393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties.
    de Souza NJ; Dohadwalla AN; Reden J
    Med Res Rev; 1983; 3(2):201-19. PubMed ID: 6345959
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii.
    Dubey MP; Srimal RC; Nityanand S; Dhawan BN
    J Ethnopharmacol; 1981 Jan; 3(1):1-13. PubMed ID: 7193263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of new water-soluble derivatives of forskolin.
    Khandelwal Y; Rajeshwari K; Rajagopalan R; Swamy L; Dohadwalla AN; de Souza NJ; Rupp RH
    J Med Chem; 1988 Oct; 31(10):1872-9. PubMed ID: 3172122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and inotropic potential of forskolin in the human heart.
    Bristow MR; Ginsburg R; Strosberg A; Montgomery W; Minobe W
    J Clin Invest; 1984 Jul; 74(1):212-23. PubMed ID: 6330174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In search of novel water soluble forskolin analogues for positive inotropic activity.
    Lal B; Gangopadhyay AK; Gidwani RM; Fernandes M; Rajagopalan R; Ghate AV
    Bioorg Med Chem; 1998 Nov; 6(11):2075-83. PubMed ID: 9881098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species differences in the positive inotropic response to DPI 201-106, a novel cardiotonic agent.
    Haleen SJ; Steffen RP; Weishaar RE
    Can J Physiol Pharmacol; 1989 Nov; 67(11):1460-3. PubMed ID: 2560676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The positive inotropic-acting forskolin, a potent adenylate cyclase activator.
    Metzger H; Lindner E
    Arzneimittelforschung; 1981; 31(8):1248-50. PubMed ID: 7197529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyacyl derivatives of forskolin--their positive inotropic activity.
    Lal B; Gangopadhyay AK; Rajagopalan R; Ghate AV
    Bioorg Med Chem; 1998 Nov; 6(11):2061-73. PubMed ID: 9881097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac adenylate cyclase activity, positive chronotropic and inotropic effects of forskolin analogs with either low, medium or high binding site affinity.
    Hubbard JW; Conway PG; Nordstrom LC; Hartman HB; Lebedinsky Y; O'Malley GJ; Kosley RW
    J Pharmacol Exp Ther; 1991 Feb; 256(2):621-7. PubMed ID: 1993999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents.
    Mertens A; Müller-Beckmann B; Kampe W; Hölck JP; von der Saal W
    J Med Chem; 1987 Aug; 30(8):1279-87. PubMed ID: 3612681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some in vitro and in vivo cardiovascular effects of Hypoxis hemerocallidea Fisch & CA Mey (Hypoxidaceae) corm (African potato) aqueous extract in experimental animal models.
    Ojewole JA; Kamadyaapa DR; Musabayane CT
    Cardiovasc J S Afr; 2006; 17(4):166-71. PubMed ID: 17001418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of LAS 31180, a new inotropic/vasodilator quinolone derivative.
    Gras J; Cardelús I; Beleta J; Gristwood RW; Palacios JM; Llenas J
    Arzneimittelforschung; 2000 Nov; 50(11):980-6. PubMed ID: 11148864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of forskolin and isoprenaline on tracheal, cardiac and skeletal muscles from guinea-pig.
    Waldeck B; Widmark E
    Eur J Pharmacol; 1985 Jun; 112(3):349-53. PubMed ID: 4040470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-inotropy relationship applied to substituted grayanotoxins.
    Shirai N; Sakakibara J; Kaiya T; Kobayashi S; Hotta Y; Takeya K
    J Med Chem; 1983 Jun; 26(6):851-5. PubMed ID: 6854587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forskolin, a new positive inotropic agent, and its influence on myocardial electrogenic cation movements.
    Späh F
    J Cardiovasc Pharmacol; 1984; 6(1):99-106. PubMed ID: 6199620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive and antiarrhythmic effects of a new alkaloid, the 13-hydroxylupanine-2-pyrrolcarbonic acid ester, from the Madagascan plant Cadia ellisiana.
    Lindner E; Kaiser J; Schacht U
    Arzneimittelforschung; 1976; 26(9):1651-7. PubMed ID: 11808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal cardiotonics. 3. New 4,5-dihydro-6-(1H-indol-5-yl)pyridazin-3(2H)-ones and related compounds with positive inotropic activities.
    Mertens A; Friebe WG; Müller-Beckmann B; Kampe W; Kling L; von der Saal W
    J Med Chem; 1990 Oct; 33(10):2870-5. PubMed ID: 2213839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.